617 related articles for article (PubMed ID: 22595924)
1. Unusually virulent coagulase-negative Staphylococcus lugdunensis is frequently associated with infective endocarditis: a Waikato series of patients.
Liang M; Mansell C; Wade C; Fisher R; Devlin G
N Z Med J; 2012 May; 125(1354):51-9. PubMed ID: 22595924
[TBL] [Abstract][Full Text] [Related]
2. The occurrence of infective endocarditis with Staphylococcus lugdunensis bacteremia: A retrospective cohort study and systematic review.
Non LR; Santos CA
J Infect; 2017 Feb; 74(2):179-186. PubMed ID: 27777118
[TBL] [Abstract][Full Text] [Related]
3. Significance of Staphylococcus lugdunensis bacteremia: report of 28 cases and review of the literature.
Zinkernagel AS; Zinkernagel MS; Elzi MV; Genoni M; Gubler J; Zbinden R; Mueller NJ
Infection; 2008 Aug; 36(4):314-21. PubMed ID: 18648747
[TBL] [Abstract][Full Text] [Related]
4. [Endocarditis caused by Staphylococcus lugdunensis. Hospital incidence].
Llinares P; Moure R; Cerqueiro J; Abalde M; Míguez E; Echaniz A; Guerrero A
Enferm Infecc Microbiol Clin; 1998 May; 16(5):233-6. PubMed ID: 9666587
[TBL] [Abstract][Full Text] [Related]
5. Successful daptomycin treatment for Staphylococcus lugdunensis endocarditis.
Stair B; Vessels B; Overholser E; Zogleman B; Wall BM; Corbett C
Am J Med Sci; 2012 Jul; 344(1):64-6. PubMed ID: 22314107
[TBL] [Abstract][Full Text] [Related]
6. Staphylococcus lugdunensis from gluteal abscess to destructive native triple valve endocarditis.
Al Majid FM
Saudi Med J; 2018 Oct; 39(10):1050-1053. PubMed ID: 30284590
[TBL] [Abstract][Full Text] [Related]
7. Clinical experience and microbiologic characteristics of invasive Staphylococcus lugdunensis infection in a tertiary center in northern Taiwan.
Lin JF; Cheng CW; Kuo AJ; Liu TP; Yang CC; Huang CT; Lee MH; Lu JJ
J Microbiol Immunol Infect; 2015 Aug; 48(4):406-12. PubMed ID: 24529852
[TBL] [Abstract][Full Text] [Related]
8. Skin and soft tissue infections caused by Staphylococcus lugdunensis: report of 20 cases.
Arias M; Tena D; Apellániz M; Asensio MP; Caballero P; Hernández C; Tejedor F; Bisquert J
Scand J Infect Dis; 2010 Dec; 42(11-12):879-84. PubMed ID: 20735327
[TBL] [Abstract][Full Text] [Related]
9. [Coagulase-negative Staphylococcus bacteraemia: prognosis factors and influence of antibiotic treatment].
Fernández-Rufete A; García-Vázquez E; Hernández-Torres A; Canteras M; Ruiz J; Gómez J
Rev Esp Quimioter; 2012 Sep; 25(3):199-205. PubMed ID: 22987266
[TBL] [Abstract][Full Text] [Related]
10. Staphylococcus lugdunensis endocarditis with isolated tricuspid valve involvement.
Chung KP; Chang HT; Liao CH; Chu FY; Hsueh PR
J Microbiol Immunol Infect; 2012 Jun; 45(3):248-50. PubMed ID: 22041168
[TBL] [Abstract][Full Text] [Related]
11. Aortic valve endocarditis from Staphylococcus lugdunensis.
Cevasco M; Haime M
J Card Surg; 2012 May; 27(3):299-300. PubMed ID: 21810116
[TBL] [Abstract][Full Text] [Related]
12. Two successfully treated cases of Staphylococcus lugdunensis endocarditis.
Chatzigeorgiou KS; Ikonomopoulou C; Kalogeropoulou S; Siafakas N; Giannopoulos G; Antoniadou A; Tassios PT; Tarpatzi E; Giannitsioti E; Vlachakos D; Ikonomopoulos T; Petinaki E; Zerva L
Diagn Microbiol Infect Dis; 2010 Dec; 68(4):445-8. PubMed ID: 21094427
[TBL] [Abstract][Full Text] [Related]
13. Staphylococcus lugdunensis: a rare but destructive cause of coagulase-negative staphylococcus infective endocarditis.
Sabe MA; Shrestha NK; Gordon S; Menon V
Eur Heart J Acute Cardiovasc Care; 2014 Sep; 3(3):275-80. PubMed ID: 24523355
[TBL] [Abstract][Full Text] [Related]
14. Staphylococcus lugdunensis infective endocarditis: a literature review and analysis of risk factors.
Liu PY; Huang YF; Tang CW; Chen YY; Hsieh KS; Ger LP; Chen YS; Liu YC
J Microbiol Immunol Infect; 2010 Dec; 43(6):478-84. PubMed ID: 21195974
[TBL] [Abstract][Full Text] [Related]
15. Staphylococcus lugdunensis: the coagulase-negative staphylococcus you don't want to ignore.
Babu E; Oropello J
Expert Rev Anti Infect Ther; 2011 Oct; 9(10):901-7. PubMed ID: 21973302
[TBL] [Abstract][Full Text] [Related]
16. [Infective endocarditis due to high level aminoglycoside resistant Enterococcus faecalis and methicillin resistant coagulase-negative staphylococci presenting with rheumatic manifestations].
Pişkin N; Akduman D; Aydemir H; Celebi G; Oztoprak N; Aktaş E
Mikrobiyol Bul; 2008 Jul; 42(3):509-14. PubMed ID: 18822897
[TBL] [Abstract][Full Text] [Related]
17. Case report of Staphylococcus lugdunensis native valve endocarditis and review of the literature.
Teong HH; Leo YS; Wong SY; Sng LH; Ding ZP
Ann Acad Med Singap; 2000 Sep; 29(5):673-7. PubMed ID: 11126708
[TBL] [Abstract][Full Text] [Related]
18. Staphylococcus lugdunensis endocarditis in children.
Guillaume MP; Dubos F; Godart F
Cardiol Young; 2017 May; 27(4):784-787. PubMed ID: 27748222
[TBL] [Abstract][Full Text] [Related]
19. Gerbode defect with Staphylococcus lugdunensis native tricuspid valve infective endocarditis.
Carpenter RJ; Price GD; Boswell GE; Nayak KR; Ramirez AR
J Card Surg; 2012 May; 27(3):316-20. PubMed ID: 22329696
[TBL] [Abstract][Full Text] [Related]
20. Retrospective case-control analysis of patients with staphylococcal infections receiving daptomycin or glycopeptide therapy.
Falcone M; Russo A; Pompeo ME; Vena A; Marruncheddu L; Ciccaglioni A; Grossi P; Mancini C; Novelli A; Stefani S; Venditti M
Int J Antimicrob Agents; 2012 Jan; 39(1):64-8. PubMed ID: 22047703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
